Patents by Inventor Mathieu Borge

Mathieu Borge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220077338
    Abstract: A semi-transparent photovoltaic module made up of a plurality of photovoltaic cells that are electrically connected in series, said cells being composed of active photovoltaic regions (2) contained in annuli referred to as active annuli, said active photovoltaic regions of a given active annulus being separated by insulating regions (4); and of vacant space (3) that forms transparent regions in transparent annuli; two adjacent annuli being separated by one transparent annulus (3) and two active photovoltaic regions (2) of adjacent active annuli belonging to the same cell being connected by at least one conductive bridge interconnect (8). Said module is characterized in that adjacent insulating regions (4) do not face each other.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Xavier Noël, Mathieu Borg
  • Publication number: 20100210584
    Abstract: The invention relates to the field of pharmaceuticals, dietary supplements and food and, more specifically, to the field of dietary supplements intended for the treatment of degradation of cartilage of any origin. The invention relates to liquid or paste compositions based on glucosamin and chondroitin sulphate, intended to provide elements essential for the synthesis and formation of proteoglycans, in which the chondroitin sulphate/glucosamin combination is stabilised with the addition of carboxylic acids such that the pH of the medium is between 2 and 5 and the chemical degradation rate of the active substances is less than 10% when stored at 25° C. and 60% relative humidity for 10 months for doses of between 300 and 2400 mg chondroitin sulphate and between 500 and 3000 mg glucosamin. The invention is suitable for the treatment of cartilage degradation and, more specifically, arthrosis.
    Type: Application
    Filed: July 4, 2008
    Publication date: August 19, 2010
    Inventors: Mathieu Borge, Patrick Laduree, Laurence Paris